BFRI · Biofrontera Inc.

Summary

Biofrontera Inc. reported record Q4 2025 revenues of $17.1 million, up 36% from $12.6 million in Q4 2024, with gross margins expanding to 82.4% from 58.0% and operating income of $4.6 million versus a $1.7 million loss prior year, driven by a strategic asset purchase from Biofrontera AG. Full year 2025 revenues rose 12% to $41.7 million with net loss narrowing to $10.5 million from $17.7 million.